197 related articles for article (PubMed ID: 1782131)
41. Fat-soluble vitamin assessment, deficiency and supplementation in infants with cholestasis.
Mancell S; Islam M; Dhawan A; Whelan K
J Hum Nutr Diet; 2022 Apr; 35(2):273-279. PubMed ID: 34679231
[TBL] [Abstract][Full Text] [Related]
42. Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.
Farrell PM; Kosorok MR; Laxova A; Shen G; Koscik RE; Bruns WT; Splaingard M; Mischler EH
N Engl J Med; 1997 Oct; 337(14):963-9. PubMed ID: 9395429
[TBL] [Abstract][Full Text] [Related]
43. Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements.
Ansari EA; Sahni K; Etherington C; Morton A; Conway SP; Moya E; Littlewood JM
Br J Ophthalmol; 1999 Jun; 83(6):688-91. PubMed ID: 10340977
[TBL] [Abstract][Full Text] [Related]
44. The risk of plasma vitamin A, C, E and D deficiency in patients with metabolic syndrome: A case-control study.
Godala M; Materek-Kuśmierkiewicz I; Moczulski D; Rutkowski M; Szatko F; Gaszyńska E; Tokarski S; Kowalski J
Adv Clin Exp Med; 2017 Jul; 26(4):581-586. PubMed ID: 28691410
[TBL] [Abstract][Full Text] [Related]
45. Nutritional assessment of infants with cystic fibrosis diagnosed through screening.
Mischler EH; Marcus MS; Sondel SA; Laxova A; Carey P; Langhough R; Farrell PM
Pediatr Pulmonol Suppl; 1991; 7():56-63. PubMed ID: 1782132
[TBL] [Abstract][Full Text] [Related]
46. The prevalence and possible causes of fat-soluble vitamin deficiencies in the world.
McLaren DS
Prog Clin Biol Res; 1981; 77():99-107. PubMed ID: 6801702
[No Abstract] [Full Text] [Related]
47. Vitamin A supplementation for cystic fibrosis.
Bonifant CM; Shevill E; Chang AB
Cochrane Database Syst Rev; 2014 May; (5):CD006751. PubMed ID: 24823814
[TBL] [Abstract][Full Text] [Related]
48. Nutritional deficiencies in the neonate.
Pereira GR; Zucker AH
Clin Perinatol; 1986 Mar; 13(1):175-89. PubMed ID: 3514049
[TBL] [Abstract][Full Text] [Related]
49. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis.
Sikkens EC; Cahen DL; Koch AD; Braat H; Poley JW; Kuipers EJ; Bruno MJ
Pancreatology; 2013; 13(3):238-42. PubMed ID: 23719594
[TBL] [Abstract][Full Text] [Related]
50. Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis.
Woestenenk JW; Broos N; Stellato RK; Arets HG; van der Ent CK; Houwen RH
Br J Nutr; 2015 Apr; 113(7):1096-101. PubMed ID: 25762411
[TBL] [Abstract][Full Text] [Related]
51. Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention.
Bertolaso C; Groleau V; Schall JI; Maqbool A; Mascarenhas M; Latham NE; Dougherty KA; Stallings VA
J Pediatr Gastroenterol Nutr; 2014 Apr; 58(4):443-8. PubMed ID: 24345827
[TBL] [Abstract][Full Text] [Related]
52. Vitamin D deficiency and its treatment in cystic fibrosis.
Daley T; Hughan K; Rayas M; Kelly A; Tangpricha V
J Cyst Fibros; 2019 Oct; 18 Suppl 2():S66-S73. PubMed ID: 31679731
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the efficiency of nanomicellar formulation of fat-soluble vitamins in patients with cystic fibrosis: the study protocol for a randomized controlled trial.
Soleimanzadeh M; Talebi S; Jaafari MR; Sayedi SJ; Emadzadeh M; Kianifar HR
Trials; 2024 Jan; 25(1):60. PubMed ID: 38229125
[TBL] [Abstract][Full Text] [Related]
54. Effect of abnormal liver function on vitamin E status and supplementation in adults with cystic fibrosis.
Stead RJ; Muller DP; Matthews S; Hodson ME; Batten JC
Gut; 1986 Jun; 27(6):714-8. PubMed ID: 3721295
[TBL] [Abstract][Full Text] [Related]
55. Hypocalcemia as the initial manifestation of occult cholestatic liver disease.
Clark JH; Hudson SD
Clin Pediatr (Phila); 1992 Jul; 31(7):428-31. PubMed ID: 1617868
[No Abstract] [Full Text] [Related]
56. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study.
Huyghebaert N; De Beer J; Vervaet C; Remon JP
J Clin Pharm Ther; 2007 Oct; 32(5):489-96. PubMed ID: 17875116
[TBL] [Abstract][Full Text] [Related]
57. Impaired brainstem auditory evoked potentials in patients with cystic fibrosis.
Vaisman N; Tabachnik E; Shahar E; Gilai A
Dev Med Child Neurol; 1996 Jan; 38(1):59-64. PubMed ID: 8606017
[TBL] [Abstract][Full Text] [Related]
58. Vitamin A intake and serum retinol levels in children and adolescents with cystic fibrosis.
Woestenenk JW; Broos N; Stellato RK; Arets HG; van der Ent CK; Houwen RH
Clin Nutr; 2016 Jun; 35(3):654-9. PubMed ID: 25975494
[TBL] [Abstract][Full Text] [Related]
59. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis.
Sitrin MD; Lieberman F; Jensen WE; Noronha A; Milburn C; Addington W
Ann Intern Med; 1987 Jul; 107(1):51-4. PubMed ID: 3592448
[TBL] [Abstract][Full Text] [Related]
60. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
Koscik RL; Lai HJ; Laxova A; Zaremba KM; Kosorok MR; Douglas JA; Rock MJ; Splaingard ML; Farrell PM
J Pediatr; 2005 Sep; 147(3 Suppl):S51-6. PubMed ID: 16202783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
